{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:23:34Z","timestamp":1779416614782,"version":"3.53.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.103282","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:16:28Z","timestamp":1776352588000},"page":"103282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Factors associated with albuminuria in non-diabetic severe obesity"],"prefix":"10.1016","volume":"73","author":[{"given":"Rapha\u00ebl","family":"Toussaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Gentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-0262","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Farigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Miolanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Elisabeth","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Boirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.103282_bib1","article-title":"The heavy burden of obesity: the economics of prevention","year":"2019","journal-title":"OECD Health Policy Studies"},{"key":"10.1016\/j.clnesp.2026.103282_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/jcm12030925","article-title":"Prevalence of overweight and obesity in France: the 2020 Obepi-Roche study by the \u201cLigue Contre l\u2019Ob\u00e9sit\u00e9.\u201d","volume":"12","author":"Fontbonne","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clnesp.2026.103282_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnesp.2026.103282_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnesp.2026.103282_bib5","doi-asserted-by":"crossref","first-page":"ckz185.548","DOI":"10.1093\/eurpub\/ckz185.548","article-title":"The constances cohort","volume":"29","author":"Zins","year":"2019","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.clnesp.2026.103282_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2026.103282_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13649","article-title":"Association of metabolic syndrome and chronic kidney disease","volume":"25","author":"Scurt","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnesp.2026.103282_bib8","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ekir.2023.06.022","article-title":"The association between metabolic syndrome, hyperfiltration, and long-term GFR decline in the general population","volume":"8","author":"Bystad","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.clnesp.2026.103282_bib9","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc12-1654","article-title":"Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?","volume":"36","author":"Hinnouho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2026.103282_bib10","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.clnesp.2026.103282_bib11","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"S2213\u20138587","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnesp.2026.103282_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.jrn.2017.01.020","article-title":"The association between the metabolic syndrome and metabolic syndrome score and urine microalbumin\/urine creatinine ratio and glomerular filtration rate in Korean adults with obesity","volume":"27","author":"Yoon","year":"2017","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.clnesp.2026.103282_bib13","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1007\/s11695-019-04011-2","article-title":"Metabolic syndrome rather than obesity alone is more significant for kidney disease","volume":"29","author":"Bagasrawala","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnesp.2026.103282_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000518111","article-title":"Metabolic syndrome, and not obesity, is associated with chronic kidney disease","volume":"52","author":"Ciardullo","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clnesp.2026.103282_bib15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/nep.13868","article-title":"Combined effect of obesity and metabolic profile on glomerular dysfunction in hypertensive subjects","volume":"26","author":"Bennouar","year":"2021","journal-title":"Nephrology"},{"key":"10.1016\/j.clnesp.2026.103282_bib16","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clnesp.2026.103282_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/oby.22134","article-title":"Metabolically healthy obesity and risk of kidney function decline","volume":"26","author":"Chang","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2026.103282_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnesp.2026.103282_bib19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.soard.2018.05.013","article-title":"Longitudinal assessment of renal function in native kidney after bariatric surgery","volume":"14","author":"Favre","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnesp.2026.103282_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnesp.2026.103282_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-8587(21)00243-6","article-title":"Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Jongs","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnesp.2026.103282_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnesp.2026.103282_bib23","series-title":"Guide des chiffres et formules utiles en pratique m\u00e9dicale","author":"Messa\u00ef","year":"1995"},{"key":"10.1016\/j.clnesp.2026.103282_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnesp.2026.103282_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2026.103282_bib26","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.21037\/jtd.2018.10.79","article-title":"Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease","volume":"10","author":"Jin","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.clnesp.2026.103282_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.endonu.2014.06.009","article-title":"Triglycerides and glucose index: a useful indicator of insulin resistance","volume":"61","author":"Unger","year":"2014","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.clnesp.2026.103282_bib28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clnesp.2026.103282_bib29","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clnesp.2026.103282_bib30","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.jacc.2018.01.082","article-title":"Predicting cardiovascular health in coronary artery risk development in young adults","volume":"71","author":"Gooding","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clnesp.2026.103282_bib31","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.5114\/amsad.2016.62137","article-title":"Metabolic syndrome severity score: range and associations with cardiovascular risk factors","volume":"1","author":"Dimitrov","year":"2016","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"10.1016\/j.clnesp.2026.103282_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3683","article-title":"Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease","author":"Bozkurt","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clnesp.2026.103282_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13307","article-title":"Unravelling gender-specific factors that link obesity to albuminuria","volume":"50","author":"Landecho","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clnesp.2026.103282_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.982519","article-title":"Normal weight and waist obesity indicated by increased total body fat associated with all-cause mortality in stage 3\u20135 chronic kidney disease","volume":"9","author":"Shen","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103282_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/oby.22134","article-title":"Metabolically healthy obesity and risk of kidney function decline","volume":"26","author":"Chang","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2026.103282_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnesp.2026.103282_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clnesp.2026.103282_bib38","article-title":"Relationship between dyslipidemia and albuminuria in hypertensive adults: a nationwide population-based study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.clnesp.2026.103282_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2612","article-title":"The triglyceride-glucose index and obesity-related risk of end-stage kidney disease in Austrian adults","volume":"4","author":"Fritz","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnesp.2026.103282_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13649","article-title":"Association of metabolic syndrome and chronic kidney disease","volume":"25","author":"Scurt","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnesp.2026.103282_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0394632016643550","article-title":"Obesity and kidney disease: beyond the hyperfiltration","volume":"29","author":"Mascali","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.clnesp.2026.103282_bib42","first-page":"291","article-title":"The kidney in chronic liver disease: circulatory abnormalities, renal sodium handling and role of natriuretic peptides","volume":"31","author":"Valdivieso","year":"1998","journal-title":"Biol Res"},{"key":"10.1016\/j.clnesp.2026.103282_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104617","article-title":"The gut-liver-kidney axis: novel regulator of fatty liver associated chronic kidney disease","volume":"152","author":"Raj","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnesp.2026.103282_bib44","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/s41598-020-62841-y","article-title":"Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study","volume":"10","author":"Yoo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2026.103282_bib45","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.clnu.2024.04.033","article-title":"Identification of factors associated with sarcopenic obesity development: literature review and expert panel voting","volume":"43","author":"Pinel","year":"2024","journal-title":"Clin Nutrition"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:30:17Z","timestamp":1779413417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"alternative-id":["S2405457726003785"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103282","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with albuminuria in non-diabetic severe obesity","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}],"article-number":"103282"}}